Bone mineral density and body composition in postmenopausal women with psoriasis and psoriatic arthritis

Arthritis Research and Therapy

Volumn 13, Issue 1, 2011, Pages

  Pedreira, Paulo G ^a   Pinheiro, Marcelo M ^a   Szejnfeld, Vera L ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY COMPOSITION; BODY FAT; BONE DENSITY; CONTROLLED STUDY; DISABILITY; DISEASE ACTIVITY SCORE 28; DISEASE DURATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FALLING; FEMALE; FEMUR; FRAGILITY FRACTURE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; LEAN BODY WEIGHT; LUMBAR SPINE; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; POSTMENOPAUSE; PREVALENCE; PSORIASIS; PSORIASIS AREA SEVERITY INDEX; PSORIASIS SEVERITY INDEX; PSORIATIC ARTHRITIS; QUESTIONNAIRE; RISK FACTOR; SCORING SYSTEM; SPINE RADIOGRAPHY; THORACIC SPINE; VERTEBRA FRACTURE; CROSS-SECTIONAL STUDY; MIDDLE AGED; PATHOPHYSIOLOGY; PHOTON ABSORPTIOMETRY; PHYSIOLOGY; POSTMENOPAUSE OSTEOPOROSIS;

ABSORPTIOMETRY, PHOTON; ARTHRITIS, PSORIATIC; BODY COMPOSITION; BONE DENSITY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; METABOLIC SYNDROME X; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; OSTEOPOROTIC FRACTURES; POSTMENOPAUSE; PREVALENCE; PSORIASIS; RISK FACTORS;

EID: 79551619392     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3240     Document Type: Article

References (43)

1. Sabat R, Philipp S, Höflich C, Kreutzer S, Wallace E, Asadullah K, Volk HD, Sterry W, Wolk K. Immunopathogenesis of psoriasis. Exp Dermatol 2007, 16:779-798. 10.1111/j.1600-0625.2007.00629.x, 17845210.
2. Tschachler E. Psoriasis: the epidermal component. Clin Dermatol 2007, 25:589-595. 10.1016/j.clindermatol.2007.09.021, 18021897.
3. Veale D, Ritchlin C, FitzGerald O. Immunopathology of psoriasis and psoriatic arthritis. Ann Rheum Dis 2005, 65:26-29. 1797973, 15941839.
4. Fearon U, Griosios K, Fraser A, Reece R, Emery P, Jones PF, Veale DJ. Angiopoietins, growth factors, and vascular morphology in early arthritis. J Rheumatol 2003, 30:260-268.
5. Ritchlin CT, Haas-Smith SA, Li P, Hicks DG, Schwarz EM. Mechanisms of TNF alpha and RANK mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J Clin Invest 2003, 111:821-831. 153764, 12639988.
6. Colucci S, Brunetti G, Cantatore FP, Oranger A, Mori G, Quarta L, Cirulli N, Mancini L, Corrado A, Grassi FR, Grano M. Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFalpha, and IL-7 in an in vitro model derived from human psoriatic arthritis. J Pathol 2007, 212:47-55. 10.1002/path.2153, 17370327.
7. Hofbauer LC, Schoppet M, Christ M, Teichmann J, Lange U. Tumour necrosis factor-related apoptosis-inducing ligand and osteoprotegerin serum levels in psoriatic arthritis. Rheumatology 2006, 45:1218-1222. 10.1093/rheumatology/kel108, 16574701.
8. Ng V, Gibbs A, Radovits B, Murray B, Brady J, Bresnihan B, Veale DJ, McKenna M, FitzGerald O. Bone biomarkers and bone density measurements in psoriatic arthritis and rheumatoid arthritis patients prior to and following anti-TNF therapy. Annual European Congress of Rheumatology - EULAR 2008; Paris. Annals of the Rheumatic Diseases - The EULAR Journal 2008, 525.
9. Nymann P, Kollerup G, Jemec GB, Grossmann E. Decreased bone mineral density in patients with pustulosis palmaris et plantaris. Dermatology 1996, 192:307-311. 10.1159/000246400, 8864362.
10. Millard TP, Antoniades L, Evans AV, Smith HR, Spector TD, Barker JN. Bone mineral density of patients with chronic plaque psoriasis. Clin Exp Dermatol 2001, 26:446-448. 10.1046/j.1365-2230.2001.00855.x, 11488836.
11. Borman P, Babaoǧlu S, Gur G, Bingol S, Bodur H. Bone mineral density and bone turnover in patients with psoriatic arthritis. Clin Rheumatol 2008, 27:443-447. 10.1007/s10067-007-0725-8, 17876648.
12. Zinnuroglu M, Dincel AS, Oztas MO, Kosova F, Sepici V. Bone loss in patients with psoriatic arthritis and psoriasis vulgaris. Rheumatol Int 2007, 27:993-994. 10.1007/s00296-007-0353-2, 17468872.
13. Deschenes MR. Effects of aging on muscle fibre type and size. Sports Med 2004, 34:809-824. 10.2165/00007256-200434120-00002, 15462613.
14. Leveille SG. Musculoskeletal aging. Curr Opin Rheumatol 2004, 16:114-118. 10.1097/00002281-200403000-00007, 14770095.
15. Morley JE, Thomas DR, Wilson MM. Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr 2006, 83:735-743.
16. Toussirot E, Nguyen NU, Dumoulin G, Aubin F, Cédoz JP, Wendling D. Relationship between growth hormone-IGF-I-IGFBP-3 axis and serum leptin levels with bone mass and body composition in patients with rheumatoid arthritis. Rheumatology (Oxford) 2005, 44:120-125. 10.1093/rheumatology/keh421, 15466894.
17. Westhovens R, Nijs J, Taelman V, Dequeker J. Body composition in rheumatoid arthritis. Br J Rheumatol 1997, 36:444-448. 10.1093/rheumatology/36.4.444, 9159537.
18. Marcora S, Casanova F, Williams E, Jones J, Elamanchi R, Lemmey A. Preliminary evidence for cachexia in patients with well-established ankylosing spondylitis. Rheumatology 2006, 45:1385-1388. 10.1093/rheumatology/kel127, 16603581.
19. Briot K, Gossec L, Kolta S, Dougados M, Roux C. Prospective assessment of body weight, body composition, and bone density changes in patients with spondyloarthropathy receiving anti-tumor necrosis factor-alpha treatment. J Rheumatol 2008, 35:855-861.
20. Saraceno R, Schipani C, Mazzotta A, Esposito M, Di Renzo L, De Lorenzo A, Chimenti S. Effect of anti-tumor necrosis factor-alpha therapies on body mass index in patients with psoriasis. Pharmacol Res 2008, 57:290-295. 10.1016/j.phrs.2008.02.006, 18400510.
21. Gisondi P, Cotena C, Tessari G, Girolomoni G. Anti-tumour necrosis factor-alpha therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study. J Eur Acad Dermatol Venereol 2008, 22:341-344. 10.1111/j.1468-3083.2007.02429.x, 18005022.
22. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H. CASPAR Study Group. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006, 54:2665-2673. 10.1002/art.21972, 16871531.
23. O'Neill TW, Cooper C, Algra D, Pols H, Agnusdei D, Dequeker J, Felsenberg D, Kanis J, Kruskemper G, Raspe H, Seelbach H, Silman A. Design and development of a questionnaire for use in a multicentre study of vertebral osteoporosis in Europe: the European Vertebral Osteoporosis Study (EVOS). Rheumatol Eur 1995, 24:75-81.
24. Janssen I, Baumgartner RN, Ross R, Rosenberg IH, Roubenoff R. Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol 2004, 159:413-421. 10.1093/aje/kwh058, 14769646.
25. Giles JT, Ling SM, Ferrucci L, Bartlett SJ, Andersen RE, Towns M, Muller D, Fontaine KR, Bathon JM. Abnormal body composition phenotypes in older rheumatoid arthritis patients: association with disease characteristics and pharmacotherapies. Arthritis Rheum 2008, 59:807-815. 10.1002/art.23719, 2670994, 18512711.
26. Cesari M, Kritchevsky SB, Baumgartner RN, Atkinson HH, Penninx BW, Lenchik L, Palla SL, Ambrosius WT, Tracy RP, Pahor M. Sarcopenia, obesity, and inflammation--results from the trial of angiotensin converting enzyme inhibition and novel cardiovascular risk factors study. Am J Clin Nutr 2005, 82:428-434.
27. Fredriksson T, Pettersson V. Severe psoriasis - oral therapy with a new retinoid. Dermatologica 1978, 157:238-244. 10.1159/000250839, 357213.
28. Ferraz MB, Oliveira LM, Araujo PM, Atra E, Tugwell P. Crosscultural reliability of the physical ability dimension of the health assessment questionnaire. J Rheumatol 1990, 17:813-817.
29. Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995, 38:44-48. 10.1002/art.1780380107, 7818570.
30. Gladman DD, Mease PJ, Healy P, Helliwell PS, Fitzgerald O, Cauli A, Lubrano E, Krueger GG, van der Heijde D, Veale DJ, Kavanaugh A, Nash P, Ritchlin C, Taylor W, Stand V. Outcome measures in psoriatic arthritis. J Rheumatol 2007, 34:1159-1166.
31. Genant HK, Wu CY, van Kuijk C, Nevitt M. Vertebral fracture assessment using a semi-quantitative technique. J Bone Miner Res 1993, 8:1137-1148. 10.1002/jbmr.5650080915, 8237484.
32. Dheda K, Cassim B, Patel N, Mody GM. A comparison of bone mineral density in Indians with psoriatic polyarthritis and healthy Indian volunteers. Clin Rheumatol 2004, 23:89. 10.1007/s10067-003-0818-y, 14749995.
33. Grisar J, Bernecker PM, Aringer M, Redlich K, Sedlak M, Wolozcszuk W, Spitzauer S, Grampp S, Kainberger F, Ebner W, Smolen JS, Pietschmann P. Ankylosing spondylitis, psoriatic arthritis, and reactive arthritis show increased bone resorption, but differ with regard to bone formation. J Rheumatol 2002, 29:1430-1436.
34. Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int 1994, 4:368-381. 10.1007/BF01622200, 7696835.
35. Frediani B, Allegri A, Falsetti P, Storri L, Bisogno S, Baldi F, Filipponi P, Marcolongo R. Bone mineral density in patients with psoriatic arthritis. J Rheumatol 2001, 28:138-143.
36. Hein G, Abendroth K, Muller A, Wessel S. Studies on psoriatic osteopathy. Clin Rheumatol 1991, 10:13-17. 10.1007/BF02208026, 2065500.
37. Pinheiro MM, Schuch NJ, Genaro PS, Ciconelli RM, Ferraz MB, Martini LA. Nutrient intakes related to osteoporotic fractures in men and women--the Brazilian Osteoporosis Study (BRAZOS). Nutr J 2009, 8:6. 10.1186/1475-2891-8-6, 2646749, 19178745.
38. Osmancevic A, Landin-Wilhelmsen K, Larkö O, Mellström D, Wennberg AM, Hulthén L, Krogstad AL. UVB therapy increases 25(OH) vitamin D syntheses in postmenopausal women with psoriasis. Photodermatol Photoimmunol Photomed 2007, 23:172-178. 10.1111/j.1600-0781.2007.00301.x, 17803595.
39. Ritchlin CT. From skin to bone: translational perspectives on psoriatic disease. J Rheumatol 2008, 35:1434-1437.
40. Azfar RS, Gelfand JM. Psoriasis and metabolic disease: epidemiology and pathophysiology. Curr Opin Rheumatol 2008, 20:416-422. 10.1097/BOR.0b013e3283031c99, 18525354.
41. Sommer DM, Jenisch S, Suchan M, Christophers E, Weichenthal M. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 2006, 298:321-328. 10.1007/s00403-006-0703-z, 17021763.
42. Pinheiro MM, Ciconelli RM, Martini LA, Ferraz MB. Clinical risk factors for osteoporotic fractures in Brazilian women and men: the Brazilian Osteoporosis Study (BRAZOS). Osteoporos Int 2009, 20:399-408. 10.1007/s00198-008-0680-5, 18597037.
43. Sinigaglia L, Varenna M, Girasole G, Bianchi G. Epidemiology of osteoporosis in rheumatic diseases. Rheum Dis Clin North Am 2006, 32:631-658. 10.1016/j.rdc.2006.07.002, 17288969.